Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash Flows from Operating Activities    
Net loss $ (12,099) $ (12,488)
Adjustment to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,040 834
Amortization of intangible assets 2,645 2,767
Stock based compensation 857 993
Amortization of technology 33 33
Change in fair value of derivative liability (48) (208)
Amortization of debt discount 417 1,251
Amortization of deferred financing costs 102
Provision for doubtful accounts 221
Gain on the settlement of liabilities (262)
Gain on the sale of Sysorex Arabia (23)
Other 2 41
Changes in operating assets and liabilities:    
Accounts receivable and other receivables 741 5,691
Inventory (62) 267
Other current assets 78 523
Prepaid licenses and maintenance contracts (12) 5,644
Other assets (41) (106)
Accounts payable (6,934) 2,839
Accrued liabilities (3,561) (515)
Deferred revenue 52 (6,024)
Other liabilities (973) (101)
Total Adjustments (5,830) 14,031
Net Cash (Used in) Provided by Operating Activities (17,929) 1,543
Cash Flows Used in Investing Activities    
Purchase of property and equipment (39) (86)
Investment in capitalized software (364) (718)
Investment in technology (175)
Net Cash Flows Used in Investing Activities (578) (804)
Cash Flows from Financing Activities    
Repayments to bank facility (1,141) (4,345)
Net proceeds from issuance of common stock, preferred stock and warrants 27,961 5,570
Repayment of notes payable (113) (20)
Repayment of debenture (3,050)
Net proceeds from convertible promissory notes 2,000
Repayment of convertible promissory notes (2,662)
Net Cash Provided by (Used In) Financing Activities 26,707 (2,507)
Effect of Foreign Exchange Rate on Changes on Cash (5) (11)
Net Increase (Decrease) in Cash and Cash Equivalents 8,195 (1,779)
Cash and Cash Equivalents - Beginning of period 141 1,821
Cash and Cash Equivalents - End of period 8,336 42
Cash paid for:    
Interest 695 468
Income Taxes
Supplemental disclosures of non-cash investing and financing activities:    
Reclassification of warrants to derivative liabilities 3,773
Issuance of shares for acquisition 567
Issuance of shares for settlement of accrued interest 316
Common shares issued for extinguishment of debenture liability 1,456
Adjustments to opening retained earnings for adoption of ASC 606 $ 1,287